Tel: +44(0)20 7691 0984 Email: Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...


All the latest conference updates; those that we are attending and the studies that we are presenting

Transpharmation's EEG experts Dr. John Huxter and Dr. Sandor Kantor discussed how EEG can bridge the gap between basic research, preclinical drug discovery and human clinical trials at a virtual social (SO39) at the SfN Connectome on Tuesday 12th January at 9-10am EST (2-3pm GMT). This social stimulated discussion around what EEG measures offer the best hope for predicting clinical outcomes, probing strengths, weaknesses, and usage of measures like ASSR and MMN.


Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120



Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design